This study identifies a distinct subgroup of EBV-seropositive individuals with exceptionally low anti-EBNA-1 antibody titers who do not shed Epstein–Barr virus (EBV) in saliva. These nonshedders exhibit restricted antibody diversity and superior viral suppression despite harboring latent virus.
Background
Epstein–Barr virus (EBV) infects over 95% of adults worldwide and is implicated in autoimmune diseases and certain cancers. Elevated anti-EBNA-1 antibody titers have been associated with increased disease risk, but the significance of low titers remains unclear. Understanding host control over EBV replication, particularly the existence of individuals who do not shed virus, may reveal protective immune phenotypes. This study investigates whether low anti-EBNA-1 titers define a biologically distinct nonshedder phenotype.
Data Highlights
Group
Number of Participants
Saliva Samples Collected
EBV Shedding Frequency
Typical-range titers
17 (14 completed sampling)
168
Frequent shedding detected
Low outliers (low titers)
3
36
No detectable shedding (P = .0002)
Key Findings
Individuals with low anti-EBNA-1 IgG titers represent a distinct subgroup with no detectable EBV shedding in saliva.
All participants were confirmed EBV positive by serological and molecular assays, confirming latent infection in nonshedders.
Nonshedders showed restricted antibody diversity limited to latent and immediate–early EBV antigens.
Typical-range titer individuals frequently shed EBV in saliva, indicating active viral replication/reactivation.
The difference in shedding between groups was statistically significant (P = .0002).
Clinical Implications
Measuring anti-EBNA-1 antibody titers can help identify individuals with a nonshedder phenotype who effectively suppress EBV replication. This phenotype may confer protection against EBV-related diseases, suggesting potential for risk stratification. Understanding mechanisms underlying this viral control could inform novel therapeutic strategies targeting EBV-associated conditions.
Conclusion
This study defines a biologically distinct nonshedder phenotype characterized by low anti-EBNA-1 antibody levels, absence of salivary EBV shedding, and restricted antibody diversity. These findings highlight a natural host control mechanism over EBV replication with potential clinical relevance.
References
Original Study 2024 -- A Distinct Cutoff in Anti–EBNA-1 Antibody Levels Differentiates Salivary EBV Shedders from Non-Shedders
by João Vitor Mahler, Philippe A Bilodeau, Monique Anderson, Takahisa Mikami, Natasha Bobrowski-Khoury, Mulan Jiang, Huimin Zhu, James Nguyen, Marcelo Matiello, Michael Levy, Kjetil Bjornevik, Natalia Drosu
